Safety and Efficacy of Isolated Endoscopic Cyclophotocoagulation in Pseudophakic Patients with Primary Open-Angle Glaucoma-12-Month Follow-Up
Overview
Affiliations
Background: We evaluated the safety and efficacy of endoscopic cyclophotocoagulation (ECP) for eyes with primary open-angle glaucoma (POAG).
Methods: We included a total of 104 pseudophakic eyes treated with ECP. Visual acuity and intraocular pressure (IOP, mmHg) measurements were evaluated preoperatively and on days 1 and 7 and 2 and 12 months postoperatively. IOP ≤ 15 or ≥30% reduction from baseline were defined as therapeutic success.
Results: The mean baseline IOP was 23.89 ± 8.63, and it decreased significantly at the day 1 (16.25 ± 7.32, < 0.0001), day 7 (17.81 ± 6.37, < 0.0001), 2nd month (17.77 ± 8.54, < 0.0001) and 12th month (16.42 ± 7.05, < 0.0001) follow-up visits. Therapeutic success was achieved in 55 (61.80%) eyes at the 12-month follow-up. Patients with POAG duration longer than 10 years or those using alpha agonist eye drops had a lower rate of therapeutic success (odds ratio: 0.52, 95% CI = 0.32-0.85, < 0.05 and odds ratio: 0.92, 95% CI = 0.55-0.95, = 0.024, respectively). A longer disease course was associated with higher IOP values (Rs =+0.281; = 0.024) postoperatively. The number of antiglaucoma medications decreased significantly from 2.55 ± 1.16 to 2.11 ± 1.14 ( = 0.003). The ECP complications included a minor IOP increase (9.37%), pupil irregularity (15.73%), and the presence of fibrin (3.29%).
Conclusions: The ECP is an effective and safe option, especially in eyes with a shorter glaucoma course.
Alasbali T Oman J Ophthalmol. 2023; 16(2):211-219.
PMID: 37602189 PMC: 10433059. DOI: 10.4103/ojo.ojo_106_22.
The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review.
Saeed E, Golaszewska K, Dmuchowska D, Zalewska R, Konopinska J Int J Environ Res Public Health. 2023; 20(4).
PMID: 36833599 PMC: 9957246. DOI: 10.3390/ijerph20042904.